The suitability of restriction fragment length polymorphism (RFLP) analysis for differentiating a porcine reproductive and respiratory syndrome virus (PRRSV) vaccine strain from other North American field strains was investigated. Open reading frame 5 nucleotide sequence data of the vaccine virus, its parent strain VR-2332, and 22 other strains of PRRSV included in this study indicated that 3 restriction enzyme gel patterns characterize the vaccine virus and the parent strain genotype. The combined 3 RFLP patterns differentiate the vaccine and parent virus from other PRRSV strains. This test will be a valuable tool in epidemiologic studies and will be useful in identifying individual strains in cases of multistrain PRRSV infections.
Porcine reproductive and respiratory syndrome (PRRS) is one of the most costly diseases currently faced by the swine industry. It is characterized clinically by reproductive failure in gilts and sows, weak and sickly neonatal piglets, and a respiratory disease of nursery-age and finishing pigs. 2 Moreover, many practitioners believe that infection with PRRS virus (PRRSV) might potentiate the effects of other respiratory tract bacterial and viral pathogens. Some experimental studies support this belief whereas others do not. 5, 6, 8, 13, 14 The viral etiology of PRRS was first determined in The Netherlands with the isolation of the prototype Lelystad strain 15 and then in the United States with the prototype American strain, VR-2332. 4 Based on genome organization and replication strategy, the PRRSV is classified as a member of the family Arteriviridae. Structurally, PRRSV is an enveloped virus that contains a nucleocapsid (N) protein, a nonglycosylated membrane (M) protein, and a surface (E) glycoprotein. The E glycoprotein is encoded by open reading frame (ORF) 5. 11 A commercial modified live virus vaccine a has been used to vaccinate pigs in the United States since late 1994 and has had some limited use in other countries. More than 70 million doses have been administered to pigs by producers and swine practitioners. Although the vaccine virus is attenuated, it, like the virulent field strains of PRRSV, has the ability to persist for at least several weeks in a vaccinated pig. Consequently the source of PRRSV isolated from diagnostic samples is sometimes in doubt.
Here, we describe a differential gel electrophoresis test that distinguishes a particular vaccine virus from PRRSV field strains. The test utilizes the reverse transcriptase-polymerase chain reaction (RT-PCR) method and gives a numerical code to each isolate based on restriction fragment length polymorphism (RFLP) gel patterns.
Materials and methods
PRRSV strains were propagated on Marc-145 cells, and field strains were cloned by 3 rounds of replication at the end point dilution. The Marc-145 cells 9 were cultured in Earle's minimum essential medium, supplemented with 10% fetal bovine serum and 50 g/ml gentamicin sulfate in a humidified 5% CO 2 atmosphere at 37 C. The year and location of isolation and the passage history of the original set of 22 field strains are shown in Table 1 . These strains were isolated during a 6-yr period (1989-1994) from Canada, Guatemala, and 13 states in the USA. All of these field strains were isolated prior to the marketing of the PRRSV vaccine. a In addition, Table 1 contains the RFLP coding assignments for restriction enzymes MluI, HincII, and SacII.
Viral RNA was isolated for each strain and used as template for RT-PCR. The primers (P420 and P620) and conditions for RT-PCR were as previously described. 1 The oligonucleotide primers appear to be universally applicable in that RNA from all of the North American PRRSVs we have isolated on MARC-145 cells to date were amplified. The RT-PCR gave a DNA fragment of 716 base pairs that contained PRRSV ORF 5 (603 base pairs in length).
DNA sequencing using Taq polymerase and fluorescently 
* unk ϭ unknown number of passages.
labeled dideoxynucleotides b was performed as previously described. 1 ORF 5 sequence data were analyzed by a commercial software package c to determine restriction enzyme sites that could distinguish the PRRS vaccine virus from other PRRSV field strains.
Results
The data indicating that the vaccine virus could be distinguished were derived from sequence analysis of ORF 5 of the North American prototype PRRSV strain, VR-2332, the vaccine strain, and the 22 PRRSV strains in Table 1 , all of which were isolated from the field prior to the marketing of this vaccine, which was the first of 2 modified live virus PRRS vaccines. 1, 12 From these data a set of restriction enzymes, MluI, HincII, and SacII, was selected for RFLP analysis.
To facilitate the reporting and handling of test data, each isolate is given a numerical code for its ORF 5 RFLP pattern with enzymes, MluI, HincII, and SacII, in that order. These RFLP gel patterns are shown in Fig. 1 . MluI either does not cut (code 1) or does cut (code 2) as is the case for the vaccine virus and PRRSV VR-2332. HincII has 8 different cutting patterns, including a no cut pattern, which is designated code 1. SacII has 4 cutting patterns, including a no cut pattern (code 1). Thus, an example RFLP code for the vaccine virus is 2-5-2: MluI cuts the PCR product from the vaccine virus (code 2), the HincII pattern for the vaccine virus is code 5, and SacII cuts the vaccine PCR fragment with a code 2 pattern. In this manner, all PRRSV strains are given a code based on their ORF 5 cutting patterns.
The MluI site in ORF 5 of the vaccine strain and its parent virus, VR-2332, distinguishes these 2 viruses from the other PRRSV field strains in Table 1 . HincII differentiated the vaccine and VR-2332 viruses from 20 of the 22 original field strains; only isolates from Iowa and Kansas ( To further evaluate the RFLP differential test, an additional 50 prevaccine PRRSV field strains were obtained. These isolates were more regional than the original 22 strains: 45 were from Iowa, 4 were from Illinois, and 1 was from Minnesota. All of these viruses were isolated prior to the extensive use of the PRRS vaccine in late 1994. Forty-two PRRSV isolates came from the APHIS National Veterinary Services Laboratory collection, and 8 were isolated at the National Animal Disease Center. All 50 additional strains were distinguished from the vaccine strain and VR-2332 virus by their no-cut MluI RFLP pattern (code 1). Two of the 50 isolates (no. 90 [IA] , no. 126 [IA]) had an RFLP code of 1-5-2, indicating that they differed only in their MluI patterns, but each had the same HincII and SacII patterns as the vaccine strain and VR-2332 virus. ORF 5 sequences of these 2 isolates were aligned and compared using a computer software program. c These 2 isolates were determined to be more closely related to the vaccine/VR-2332 viruses than to either no. 4 (IA) or no. 9 (KS), the most closely related among the original 22 strains (Fig. 3A) .
Discussion
Using a series of RFLP patterns, it was possible to distinguish a PRRSV vaccine strain and the prototype North American PRRSV, VR-2332, from other PRRSV field strains. However, a second modified live PRRS vaccine virus d is not distinguishable. With this method, PRRSV strains are assigned a 3-digit RFLP code; the first digit is the MluI RFLP pattern, the second is the HincII pattern, and the last digit is the SacII pattern. Thus, the RFLP code for the vaccine virus a and the VR-2332 virus is 2-5-2, which (based on sequencing and RFLP data from 90 prevaccine field strains) is unique to these 2 viruses. These observations are derived from the original 22 PRRSV strains (Table 1) , the 50 additional prevaccine PRRSV field isolates, and published sequence data from 18 prevaccine PRRSV isolates. 1, 7, 10, 12 These data do not exclude the possibility of other prevaccine wild type PRRS viruses having 2-5-2 patterns, but probably they are rare.
Only the vaccine/VR-2332 viruses have an alanine (A) at residue 137 in a moderately conserved region of ORF 5. 1 The consensus sequence has a serine (S) at residue 137 ( Fig. 2A) for all the PRRSV strains listed in Table 1 and, in fact, for all PRRSV field strains examined so far, except for an MO1 isolate. 7 This preference for serine at residue 137 explains why only the vaccine virus a and PRRSV VR-2332 have an apparently unique MluI site in ORF 5. A G to T transversion at the first base position in codon 137 gives rise to serine 137 for the original 22 PRRSV strains (Fig. 2B ). There is also a second base change for all 22 strains at the third (wobble) position of codon 137 Figure 3 . A. Dendrogram based on ORF 5 nucleotide sequences and the RFLP code for prevaccine PRRSV isolates that cluster and are known to be more closely related to North American prototype virus VR-2332. ORF 5 nucleotide sequence for RespPRRS, no. 90 (IA) and no. 126 (IA) were determined for this study and submitted to GenBank with accession numbers AF020048, AF020049, and AF020050. Other ORF 5 sequences for VR-2332 12 for isolates no. 4 (IA) and no. 9 (KS), 1 for isolates MO1, KS1, MN1, and NE1, 7 and for isolates ISU-22, ISU-179, and ISU-1894 10 were obtained from GenBank. B. Base substitutions at codon 137 that eliminate the MluI site for these clustered isolates.
(either G to A or G to T; Fig. 2B ). Virus VR-2332 is an early North American PRRSV; tissue samples containing this virus were collected from a farm in Minnesota in 1989 (J. Collins, personal communication) . Other PRRSV field isolates may have evolved from VR-2332; thus, serine, rather than the original alanine, may be the preferred amino acid at residue 137. Another equally likely explanation is that VR-2332 is not a direct ancestor of current field isolates but represents an early branch on the main evolutionary tree. In either case, the reason for a unique MluI site in the vaccine/ VR-2332 viruses is due to the less common presence of alanine at residue 137.
A dendrogram of PRRSV strains that are most closely related to the North American prototype virus VR-2332 is shown in Fig. 3A . All 10 PRRSV strains in this cluster were isolated before the release of the PRRS vaccine, a and all lack an MluI site, thus differentiating them from the vaccine strain and VR-2332. Each of these closely related isolates encodes a serine at residue 137 because of a G to T transversion at the first base of codon 137 (Fig. 3B ).
The MO1 isolate (from MO, also shown in Fig. 3A ) is more distantly related to this cluster group. The MO1 isolate was included in this analysis because both MO1 and VR-2332 contain an alanine at residue 137 (a G at the first base position for the codon); however, MO1 lacks an MluI site because of 2 other base substitutions at the MluI site. Viruses such as VR-2332 and MO1 with an alanine at residue 137 appear to be rare, suggesting that serine is the preferred amino acid in this moderately conserved region of ORF5. 1 Although a serine to alanine substitution is a relatively conservative amino acid change, it may be an important feature for the structure of the glycoprotein E molecule. Computer-generated secondary structure profiles 3 indicate that glycoprotein E molecules with an alanine at residue 137 (i.e., VR-2332, RespPRRS, MO1) have a continuous ␤ sheet through residue 137, whereas molecules with a serine at residue 137 have an extra turn in their structure in that region.
At the present time PRRS serology is at a stage where an individual pig or an entire herd is identified as having been infected or not. No differential serologic test to distinguish vaccinated animals from fieldvirus-infected pigs exists. Thus, to fill this important niche, the RFLP test as described here was developed as a means to differentiate 1 of the 2 modified live virus vaccine strains from field strains of PRRSV. The differential test has become widely used because PRRSV persists in a herd or an individual pig and is easily isolated. The use of 3 restriction enzymes gives a high level of assurance of identifying the vaccine virus even if some genomic change and drift occur in ORF 5 during virus replication in vivo. Other additional restriction enzymes can also be used to follow the epidemiology of individual PRRSV strains.
